Osaic Holdings’s Alterity Therapeutics ATHE Stock Holding History

Osaic Holdings’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$362	Hold	68	–	–	﹤0.01%	7704
2026 Q1	$240	Sell	68 -13	-16%	-$44	﹤0.01%	7537
2025 Q4	$247	Sell	81 -100	-55%	-$382	﹤0.01%	7553
2025 Q3	$889	Hold	181	–	–	﹤0.01%	7396
2025 Q2	$740	Hold	181	–	–	﹤0.01%	7250
2025 Q1	$626	Hold	181	–	–	﹤0.01%	6945
2024 Q4	$598	Buy	181 +100	+123%	+$159	﹤0.01%	6975
2024 Q3	$105	Hold	81	–	–	﹤0.01%	7243
2024 Q2	$145	Hold	81	–	–	﹤0.01%	7201
2024 Q1	$165	Hold	81	–	–	﹤0.01%	6985
2023 Q4	$200	Hold	81	–	–	﹤0.01%	7040
2023 Q3	$199	Hold	81	–	–	﹤0.01%	7156
2023 Q2	$224	Hold	81	–	–	﹤0.01%	7186
2023 Q1	$223	Sell	81 -1	-1%	-$3	﹤0.01%	7250
2022 Q4	$0	Hold	82	–	–	﹤0.01%	7162
2022 Q3	$0	Buy	82 +44	+116%	+$258	﹤0.01%	7242
2022 Q2	$0	Hold	38	–	–	﹤0.01%	7319
2022 Q1	$0	Hold	38	–	–	﹤0.01%	7226
2021 Q4	$0	Hold	38	–	–	﹤0.01%	7367
2021 Q3	$0	Hold	38	–	–	﹤0.01%	7171
2021 Q2	$0	Hold	38	–	–	﹤0.01%	6980
2021 Q1	$0	Hold	38	–	–	﹤0.01%	6790
2020 Q4	$0	Buy	38 +14	+58%	+$221	﹤0.01%	6383
2020 Q3	$0	Hold	24	–	–	﹤0.01%	6194
2020 Q2	$0	Hold	24	–	–	﹤0.01%	6097
2020 Q1	$0	Buy	+24	New	+$165	﹤0.01%	6045

Other funds holding ATHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PCA

Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return

Osaic Holdings's ATHE Position: Q2 2026 in Review

Osaic Holdings held its Alterity Therapeutics (ATHE) position steady in Q2 2026 at 68 shares worth $362. The position accounts for ﹤0.01% of the portfolio, ranked #7704.

Osaic Holdings first reported a position in ATHE in Q1 2020 and has held it in 26 quarters since. The position peaked at $889 in Q3 2025. 21 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

Osaic Holdings held 68 shares of Alterity Therapeutics worth $362 as of Q2 2026.
Osaic Holdings left its Alterity Therapeutics share count unchanged in Q2 2026.
Alterity Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7704 holding.
Osaic Holdings first reported a position in Alterity Therapeutics in Q1 2020 and has held it in 26 quarters since.
Osaic Holdings's Alterity Therapeutics position peaked at $889 in Q3 2025.
21 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.